STE
US EQUITY
Health Care
Health Care Equipment
CIK: 1757898
Steris (STE) Quant Factor Diagnostic & Fair Value Model
Steris (Ticker: STE) is listed in the Health Care sector (Health Care Equipment). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$232.15
-0.03%
Latest Close (2026-10-23)
Market Cap: $51.22M
P/E Ratio: 26.6
Momentum Strength
3M / 12M
+6.30%
1M: +11.20%
12M: -4.22%
Quality (ROE)
Point-in-Time
+11.08%
Trailing Return on Equity
Technical Trend
RSI 14
75.3
SMA50: $220.26
SMA200: $225.50
Valuation Multiplier
Trailing
26.6
Moderate Valuation Corridor (15x - 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Moderate Valuation Corridor (15x - 30x P/E)
STE trades within a typical sector multiple band (26.6x P/E), broadly aligned with trailing earnings.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线整理 (MA20/50)
Piotroski F-Score: 5/9 (Moderate Financial Health)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1757898 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-08-07 | $1.49B | $200.10M | $367.10M | - |
| 10-Q | 2026-03-31 | 2026-08-07 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-08-07 | $1.39B | $177.40M | $420.00M | $1.79 |
| 10-K | 2026-03-31 | 2026-05-29 | $5.94B | $782.30M | $1.34B | $7.93 |
| 10-K | 2025-03-31 | 2026-05-29 | $5.46B | $614.60M | $1.15B | $6.20 |
| 10-K | 2024-03-31 | 2026-05-29 | $1.42B | -$1.38M | $973.30M | $-0.01 |
| 10-Q | 2025-12-31 | 2026-02-06 | $1.50B | $192.90M | $1.01B | $1.96 |
| 10-Q | 2025-03-31 | 2026-02-06 | - | - | - | - |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Steris (STE) valuation multiples, momentum factors, and point-in-time filing conventions.
How should STE's current valuation multiple be interpreted? ↓
STE trades at a trailing P/E of 26.6x within the Health Care sector (moderate valuation corridor (15x - 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are STE's key momentum and technical factor indicators? ↓
As of the latest close, STE shows a 1-month return of +11.20%, 3-month return of +6.30%, and 12-month return of -4.22%, with a 14-day RSI of 75.3. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for STE? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can STE be incorporated into systematic factor models? ↓
STE can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.